ETFs Are Net Sellers of ResMed (RMD) on Oct. 16

gurufocus.com · 2026-10-20

FTCS drove the move, shedding $180.9 million of ResMed (RMD) on Friday, Oct. 16, as ETF activity left the stock with a net $198.0 million in selling. More funds

TickrTrends take: ResMed operates in the Healthcare sector and trades at a valuation that TickrTrends currently assesses as undervalued. Net selling pressure from ETFs, as occurred on October 16, can create temporary price weakness in individual healthcare holdings that may represent value opportunities for investors focused on fundamental valuations rather than short-term flows. Given the undervalued designation, readers should monitor whether such ETF-driven selling continues or reverses, as this technical activity could either create or eliminate entry points depending on how it affects the stock's relationship to its assessed intrinsic value.

Read the full story at gurufocus.com →